AI.NYSEC3ai, INC

Form 4: C3.ai Director Richard Levin Executes Stock Option and Sells Shares Under 10b5-1 Plan

Sentiment:

SEC Form 4 Filing


Director Richard Levin exercised stock options and sold 72,000 shares of C3.ai Class A Common Stock on December 9, 2024, under a pre-arranged 10b5-1 trading plan.

Summary

  • Richard Levin, a director at C3.ai, executed a stock option to acquire 72,000 shares of Class A Common Stock at a price of $4.68 per share on December 9, 2024.
  • Concurrently, Mr. Levin sold 72,000 shares of Class A Common Stock at a weighted average price of $42 per share, with individual sales ranging from $42.00 to $42.05.
  • These transactions were conducted under a pre-established Rule 10b5-1 trading plan dated September 28, 2023.
  • Following these transactions, Mr. Levin directly owns 161,664 shares of Class A Common Stock and 63,955 stock options.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. The exercise of options and sale of shares is a routine transaction under a pre-arranged plan. The sale price is significantly higher than the exercise price, which is a positive for the director.

Positives

  • The execution of the stock option indicates the director's belief in the company's long-term value.
  • The sale of shares at $42 per share represents a significant gain over the option exercise price of $4.68.

Negatives

  • The sale of 72,000 shares could be perceived as a negative signal by some investors, although it is part of a pre-planned trading strategy.

Risks

  • The vesting of stock options is contingent on the director's attendance at board meetings, which could be a risk if attendance requirements are not met.
  • The market may react negatively to the sale of shares by a director, even if it is part of a pre-planned trading strategy.

Future Outlook

The document does not contain any specific forward-looking statements or guidance.

Industry Context

This filing is a routine disclosure of insider transactions, which is common for publicly traded companies. It provides transparency into the trading activities of company directors.

Comparison to Industry Standards

  • The use of a 10b5-1 trading plan is a common practice among corporate insiders to avoid accusations of insider trading.
  • The vesting schedule of the stock options, contingent on board meeting attendance, is a typical incentive structure for directors.
  • The sale of shares by a director is a normal occurrence and is often part of a diversified investment strategy.

Stakeholder Impact

  • The sale of shares by a director could have a minor impact on shareholder sentiment, although it is part of a pre-planned trading strategy.
  • The vesting of stock options provides an incentive for the director to remain engaged with the company.

Key Dates

DateDescription
09/28/2023Date of the establishment of the Rule 10b5-1 trading plan.
10/17/2019Commencement date for the vesting of stock options, contingent on board meeting attendance.
12/09/2024Date of the stock option exercise and share sale.
12/11/2024Date of the filing of the Form 4.
10/18/2029Expiration date of the stock options.

Keywords

C3.ai, Richard Levin, stock options, share sale, Form 4, Rule 10b5-1, insider trading, director, equity

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.